Tapewire

Nasdaq · USD

MNPR

Monopar Therapeutics

Export transactions ↓
Tapewire entity
5152
SEC CIK
0001645469
Parsed reports
244

Last 12 months

Inside the activity.

1 purchase rows · 28 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202512
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 2026019
Sep 202604
Oct 202603

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 30, 2024 Filed Jul 2, 2024 22:12 UTC
Cittadine AndrewChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 8,952 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-022025 · rdgdoc.xml · derivative · entry 3

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,271

Underlying: Common Stock · 8,952 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units.

F3 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 65,000 restricted stock units, vesting 6/48ths (8,125 shares) on June 30, 2022, and 3/48ths (4,063 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F4 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F3 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 65,000 restricted stock units, vesting 6/48ths (8,125 shares) on June 30, 2022, and 3/48ths (4,063 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F4 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

Read SEC document
June 30, 2024 Filed Jul 2, 2024 22:12 UTC
Cittadine AndrewChief Operating Officer
Tax withholdingCommon Stock 2,019 $0.73 $1,475.89
Disclosure

SEC source: 0001437749-24-022025 · rdgdoc.xml · nonDerivative · entry 2

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 193,065

F2 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.

Read SEC document
June 30, 2024 Filed Jul 2, 2024 22:12 UTC
Cittadine AndrewChief Operating Officer
Exercise / conversionCommon Stock 8,952 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-24-022025 · rdgdoc.xml · nonDerivative · entry 1

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 195,084

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents shares acquired on vesting and settlement of restricted stock units.

Read SEC document
June 30, 2024 Filed Jul 2, 2024 22:08 UTC
Tsuchimoto Kim RDirector · Chief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 9,957 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-022024 · rdgdoc.xml · derivative · entry 3

Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,412

Underlying: Common Stock · 9,957 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units.

F3 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F4 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 61,532 restricted stock units, vesting 6/48ths (7,692 shares) on June 30, 2022, and 3/48ths (3,846 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F5 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F3 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F4 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 61,532 restricted stock units, vesting 6/48ths (7,692 shares) on June 30, 2022, and 3/48ths (3,846 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F5 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

Read SEC document
June 30, 2024 Filed Jul 2, 2024 22:08 UTC
Tsuchimoto Kim RDirector · Chief Financial Officer
Tax withholdingCommon Stock 2,998 $0.73 $2,191.54
Disclosure

SEC source: 0001437749-24-022024 · rdgdoc.xml · nonDerivative · entry 2

Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,429

F2 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.

Read SEC document
June 30, 2024 Filed Jul 2, 2024 22:08 UTC
Tsuchimoto Kim RDirector · Chief Financial Officer
Exercise / conversionCommon Stock 9,957 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-24-022024 · rdgdoc.xml · nonDerivative · entry 1

Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,427

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents shares acquired on vesting and settlement of restricted stock units.

Read SEC document
June 30, 2024 Filed Jul 2, 2024 22:07 UTC
Robinson ChandlerDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 24,476 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-022023 · rdgdoc.xml · derivative · entry 5

Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,335

Underlying: Common Stock · 24,476 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units.

F5 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 63,060 restricted stock units, vesting 6/48ths (7,883 shares) on June 30, 2021, and 3/48ths (3,941 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F6 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 159,522 restricted stock units, vesting 6/48ths (19,940 shares) on June 30, 2022, and 3/48ths (9,970 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F7 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 169,012 restricted stock units, vesting 6/48ths (21,127 shares) on June 30, 2023, and 3/48ths (10,563 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F5 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 63,060 restricted stock units, vesting 6/48ths (7,883 shares) on June 30, 2021, and 3/48ths (3,941 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F6 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 159,522 restricted stock units, vesting 6/48ths (19,940 shares) on June 30, 2022, and 3/48ths (9,970 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F7 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 169,012 restricted stock units, vesting 6/48ths (21,127 shares) on June 30, 2023, and 3/48ths (10,563 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

Read SEC document
June 30, 2024 Filed Jul 2, 2024 22:07 UTC
Robinson ChandlerDirector · Chief Executive Officer
Tax withholdingCommon Stock 8,684 $0.73 $6,348.00
Disclosure

SEC source: 0001437749-24-022023 · rdgdoc.xml · nonDerivative · entry 2

Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 265,922.8

F2 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.

Read SEC document
June 30, 2024 Filed Jul 2, 2024 22:07 UTC
Robinson ChandlerDirector · Chief Executive Officer
Exercise / conversionCommon Stock 24,476 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-24-022023 · rdgdoc.xml · nonDerivative · entry 1

Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 274,606.8

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents shares acquired on vesting and settlement of restricted stock units.

Read SEC document
June 20, 2024 Filed Jun 21, 2024 21:16 UTC
Cittadine AndrewChief Operating Officer
PurchaseCommon Stock 20,508 $0.74 $15,253.85
Disclosure

SEC source: 0001437749-24-021000 · rdgdoc.xml · nonDerivative · entry 2

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,132

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.73691 to $0.75860, inclusive. The reporting person undertakes to provide to Monopar Therapeutics, any security holder of Monopar Therapeutics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the preceding sentence.

Read SEC document
June 18, 2024 Filed Jun 21, 2024 21:16 UTC
Cittadine AndrewChief Operating Officer
PurchaseCommon Stock 12,000 $0.86 $10,320.00
Disclosure

SEC source: 0001437749-24-021000 · rdgdoc.xml · nonDerivative · entry 1

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,624

Read SEC document
June 17, 2024 Filed Jun 17, 2024 22:08 UTC
Cittadine AndrewChief Operating Officer
PurchaseCommon Stock 12,000 $0.90 $10,798.80
Disclosure

SEC source: 0001437749-24-020547 · rdgdoc.xml · nonDerivative · entry 3

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,624

Read SEC document
June 14, 2024 Filed Jun 17, 2024 22:08 UTC
Cittadine AndrewChief Operating Officer
PurchaseCommon Stock 12,000 $0.93 $11,175.60
Disclosure

SEC source: 0001437749-24-020547 · rdgdoc.xml · nonDerivative · entry 2

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,624

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9100 to $0.93994, inclusive. The reporting person undertakes to provide to Monopar Therapeutics, any security holder of Monopar Therapeutics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the preceding sentence.

Read SEC document
June 13, 2024 Filed Jun 17, 2024 22:08 UTC
Cittadine AndrewChief Operating Officer
PurchaseCommon Stock 12,000 $0.91 $10,920.00
Disclosure

SEC source: 0001437749-24-020547 · rdgdoc.xml · nonDerivative · entry 1

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,624

Read SEC document
June 04, 2024 Filed Jun 5, 2024 22:12 UTC
Cittadine AndrewChief Operating Officer
PurchaseCommon Stock 12,000 $0.78 $9,360.00
Disclosure

SEC source: 0001437749-24-019370 · rdgdoc.xml · nonDerivative · entry 2

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,624

Read SEC document
June 03, 2024 Filed Jun 5, 2024 22:12 UTC
Cittadine AndrewChief Operating Officer
PurchaseCommon Stock 12,000 $0.76 $9,120.00
Disclosure

SEC source: 0001437749-24-019370 · rdgdoc.xml · nonDerivative · entry 1

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,624

Read SEC document
May 31, 2024 Filed May 31, 2024 20:56 UTC
Cittadine AndrewChief Operating Officer
PurchaseCommon Stock 12,000 $0.64 $7,731.60
Disclosure

SEC source: 0001437749-24-018931 · rdgdoc.xml · nonDerivative · entry 3

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,624

F3 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.61 to $0.6502, inclusive. The reporting person undertakes to provide to Monopar Therapeutics, any security holder of Monopar Therapeutics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the preceding sentence.

Read SEC document
May 30, 2024 Filed May 31, 2024 20:56 UTC
Cittadine AndrewChief Operating Officer
PurchaseCommon Stock 12,000 $0.64 $7,676.40
Disclosure

SEC source: 0001437749-24-018931 · rdgdoc.xml · nonDerivative · entry 2

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,624

F2 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.629 to $0.64, inclusive. The reporting person undertakes to provide to Monopar Therapeutics, any security holder of Monopar Therapeutics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the preceding sentence.

Read SEC document
May 29, 2024 Filed May 31, 2024 20:56 UTC
Cittadine AndrewChief Operating Officer
PurchaseCommon Stock 12,000 $0.64 $7,642.80
Disclosure

SEC source: 0001437749-24-018931 · rdgdoc.xml · nonDerivative · entry 1

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,624

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.629 to $0.637, inclusive. The reporting person undertakes to provide to Monopar Therapeutics, any security holder of Monopar Therapeutics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the preceding sentence.

Read SEC document
May 28, 2024 Filed May 30, 2024 22:10 UTC
Robinson ChandlerDirector · Chief Executive Officer
OtherStock Options · Derivative 84,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001437749-24-018775 · rdgdoc.xml · derivative · entry 4

Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 84,000 shares

Expires 2026-04-03

F4 · derivative.exercise_date: Reflects options to purchase up to 84,000 shares of common stock granted to Dr. Robinson on April 4, 2016 for his services as a director and officer of Monopar Therapeutics. The options vested 50% upon grant date, 25% upon the 6-month anniversary of grant date, and 25% upon the 1-year anniversary of grant date.

Read SEC document
May 28, 2024 Filed May 30, 2024 22:10 UTC
Robinson ChandlerDirector · Chief Executive Officer
OtherCommon Stock 84,000 $0.00 $84.00
Disclosure

SEC source: 0001437749-24-018775 · rdgdoc.xml · nonDerivative · entry 1

Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,130.8

F1 · shares: This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock.

Read SEC document
May 22, 2024 Filed May 24, 2024 20:59 UTC
Cittadine AndrewChief Operating Officer
GrantStock Options · Derivative 25,000 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0001437749-24-018353 · rdgdoc.xml · derivative · entry 1

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-05-22

F1 · derivative.exercise_date: Options vest 6/48ths on November 21, 2024 and 1/48th per month thereafter.

Read SEC document
March 31, 2024 Filed Apr 3, 2024 00:35 UTC
Cittadine AndrewChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 8,952 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-010723 · rdgdoc.xml · derivative · entry 3

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,223

Underlying: Common Stock · 8,952 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units.

F3 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 65,000 restricted stock units, vesting 6/48ths (8,125 shares) on June 30, 2022, and 3/48ths (4,063 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F4 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F3 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 65,000 restricted stock units, vesting 6/48ths (8,125 shares) on June 30, 2022, and 3/48ths (4,063 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F4 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

Read SEC document
March 31, 2024 Filed Apr 3, 2024 00:35 UTC
Cittadine AndrewChief Operating Officer
Tax withholdingCommon Stock 3,098 $0.68 $2,109.74
Disclosure

SEC source: 0001437749-24-010723 · rdgdoc.xml · nonDerivative · entry 2

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,624

F2 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.

Read SEC document
March 31, 2024 Filed Apr 3, 2024 00:35 UTC
Cittadine AndrewChief Operating Officer
Exercise / conversionCommon Stock 8,952 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-24-010723 · rdgdoc.xml · nonDerivative · entry 1

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,722

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents shares acquired on vesting and settlement of restricted stock units.

Read SEC document
March 31, 2024 Filed Apr 3, 2024 00:33 UTC
Tsuchimoto Kim RDirector · Chief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 9,956 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-010722 · rdgdoc.xml · derivative · entry 3

Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,369

Underlying: Common Stock · 9,956 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units.

F3 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F4 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 61,532 restricted stock units, vesting 6/48ths (7,692 shares) on June 30, 2022, and 3/48ths (3,846 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F5 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F3 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F4 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 61,532 restricted stock units, vesting 6/48ths (7,692 shares) on June 30, 2022, and 3/48ths (3,846 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F5 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

Read SEC document
March 31, 2024 Filed Apr 3, 2024 00:33 UTC
Tsuchimoto Kim RDirector · Chief Financial Officer
Tax withholdingCommon Stock 4,082 $0.68 $2,779.84
Disclosure

SEC source: 0001437749-24-010722 · rdgdoc.xml · nonDerivative · entry 2

Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,470

F2 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.

Read SEC document
March 31, 2024 Filed Apr 3, 2024 00:33 UTC
Tsuchimoto Kim RDirector · Chief Financial Officer
Exercise / conversionCommon Stock 9,956 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-24-010722 · rdgdoc.xml · nonDerivative · entry 1

Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,552

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents shares acquired on vesting and settlement of restricted stock units.

Read SEC document
March 31, 2024 Filed Apr 3, 2024 00:33 UTC
Robinson ChandlerDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 24,474 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-010721 · rdgdoc.xml · derivative · entry 5

Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 197,811

Underlying: Common Stock · 24,474 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units.

F5 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 63,060 restricted stock units, vesting 6/48ths (7,883 shares) on June 30, 2021, and 3/48ths (3,941 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F6 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 159,522 restricted stock units, vesting 6/48ths (19,940 shares) on June 30, 2022, and 3/48ths (9,970 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F7 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 169,012 restricted stock units, vesting 6/48ths (21,127 shares) on June 30, 2023, and 3/48ths (10,563 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F5 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 63,060 restricted stock units, vesting 6/48ths (7,883 shares) on June 30, 2021, and 3/48ths (3,941 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F6 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 159,522 restricted stock units, vesting 6/48ths (19,940 shares) on June 30, 2022, and 3/48ths (9,970 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F7 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 169,012 restricted stock units, vesting 6/48ths (21,127 shares) on June 30, 2023, and 3/48ths (10,563 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

Read SEC document
March 31, 2024 Filed Apr 3, 2024 00:33 UTC
Robinson ChandlerDirector · Chief Executive Officer
Tax withholdingCommon Stock 7,172 $0.68 $4,884.13
Disclosure

SEC source: 0001437749-24-010721 · rdgdoc.xml · nonDerivative · entry 2

Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,130.8

F2 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.

Read SEC document
March 31, 2024 Filed Apr 3, 2024 00:33 UTC
Robinson ChandlerDirector · Chief Executive Officer
Exercise / conversionCommon Stock 24,474 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-24-010721 · rdgdoc.xml · nonDerivative · entry 1

Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,302.8

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents shares acquired on vesting and settlement of restricted stock units.

Read SEC document
March 31, 2024 Filed Apr 3, 2025 01:08 UTC
Cittadine AndrewChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 1,791 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-010810 · rdgdoc.xml · derivative · entry 3

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,864

Underlying: Common Stock · 1,791 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units.

F3 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 13,000 restricted stock units, vesting 6/48ths (1,625 shares) on June 30, 2022, and 3/48ths (813 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F4 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 15,647 restricted stock units, vesting 6/48ths (1,956 shares) on June 30, 2023, and 3/48ths (978 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F3 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 13,000 restricted stock units, vesting 6/48ths (1,625 shares) on June 30, 2022, and 3/48ths (813 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F4 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 15,647 restricted stock units, vesting 6/48ths (1,956 shares) on June 30, 2023, and 3/48ths (978 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

Read SEC document
January 01, 2024 Filed Jan 4, 2024 00:33 UTC
RIOUX PATRICEActing Chief Medical Officer
GrantStock Options · Derivative 10,000 $0.00 Strike: $0.34 $0.00
Disclosure

SEC source: 0001437749-24-000479 · rdgdoc.xml · derivative · entry 1

RIOUX PATRICE · CIK 0001241033 · Acting Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2033-12-31

F1 · derivative.exercise_date: Stock Options vesting commenced on January 1, 2024 as follows: 833 on January 31, 2024 and each subsequent month-end thereafter.

Read SEC document
January 01, 2024 Filed Jan 4, 2024 00:34 UTC
Tsuchimoto Kim RDirector · Chief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 1,231 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-000480 · rdgdoc.xml · derivative · entry 6

Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,325

Underlying: Common Stock · 1,231 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units.

F6 · derivative.exercise_date: On January 31, 2020 the reporting person was granted 4,923 restricted stock units, vesting in four equal annual installments with vesting dates on January 1, 2021, January 1, 2022, January 1, 2023, and January 1, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F6 · derivative.expiration_date: On January 31, 2020 the reporting person was granted 4,923 restricted stock units, vesting in four equal annual installments with vesting dates on January 1, 2021, January 1, 2022, January 1, 2023, and January 1, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

Read SEC document
January 01, 2024 Filed Jan 4, 2024 00:34 UTC
Tsuchimoto Kim RDirector · Chief Financial Officer
Tax withholdingCommon Stock 505 $0.34 $171.80
Disclosure

SEC source: 0001437749-24-000480 · rdgdoc.xml · nonDerivative · entry 4

Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,596

F2 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.

Read SEC document
January 01, 2024 Filed Jan 4, 2024 00:34 UTC
Tsuchimoto Kim RDirector · Chief Financial Officer
Exercise / conversionCommon Stock 1,231 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-24-000480 · rdgdoc.xml · nonDerivative · entry 3

Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,101

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents shares acquired on vesting and settlement of restricted stock units.

Read SEC document
January 01, 2024 Filed Jan 4, 2024 00:36 UTC
Robinson ChandlerDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 6,724 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-000482 · rdgdoc.xml · derivative · entry 10

Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 222,285

Underlying: Common Stock · 6,724 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units.

F8 · derivative.exercise_date: On January 31, 2020 the reporting person was granted 26,895 restricted stock units, vesting in four equal annual installments with vesting dates on January 1, 2021, January 1, 2022, January 1, 2023, and January 1, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F8 · derivative.expiration_date: On January 31, 2020 the reporting person was granted 26,895 restricted stock units, vesting in four equal annual installments with vesting dates on January 1, 2021, January 1, 2022, January 1, 2023, and January 1, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

Read SEC document
January 01, 2024 Filed Jan 4, 2024 00:36 UTC
Robinson ChandlerDirector · Chief Executive Officer
Tax withholdingCommon Stock 2,327 $0.34 $791.65
Disclosure

SEC source: 0001437749-24-000482 · rdgdoc.xml · nonDerivative · entry 6

Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,828.8

F2 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.

Read SEC document
January 01, 2024 Filed Jan 4, 2024 00:36 UTC
Robinson ChandlerDirector · Chief Executive Officer
Exercise / conversionCommon Stock 6,724 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-24-000482 · rdgdoc.xml · nonDerivative · entry 5

Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,155.8

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents shares acquired on vesting and settlement of restricted stock units.

Read SEC document
December 31, 2023 Filed Jan 3, 2024 19:40 UTC Exercise / conversionRestricted Stock Units · Derivative 2,533 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-000487 · rdgdoc.xml · derivative · entry 4

Brown Michael J · CIK 0001035909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,533 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units.

F4 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F4 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

Read SEC document
December 31, 2023 Filed Jan 3, 2024 19:40 UTC Exercise / conversionCommon Stock 2,533 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-24-000487 · rdgdoc.xml · nonDerivative · entry 1

Brown Michael J · CIK 0001035909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 235,863

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents shares acquired on vesting and settlement of restricted stock units.

Read SEC document
December 31, 2023 Filed Jan 4, 2024 00:39 UTC
Cittadine AndrewChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 8,952 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-000486 · rdgdoc.xml · derivative · entry 3

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,175

Underlying: Common Stock · 8,952 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units.

F2 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 65,000 restricted stock units, vesting 6/48ths (8,125 shares) on June 30, 2022, and 3/48ths (4,063 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F4 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F2 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 65,000 restricted stock units, vesting 6/48ths (8,125 shares) on June 30, 2022, and 3/48ths (4,063 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F4 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

Read SEC document
December 31, 2023 Filed Jan 4, 2024 00:39 UTC
Cittadine AndrewChief Operating Officer
Tax withholdingCommon Stock 3,098 $0.34 $1,053.94
Disclosure

SEC source: 0001437749-24-000486 · rdgdoc.xml · nonDerivative · entry 2

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,770

F3 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.

Read SEC document
December 31, 2023 Filed Jan 4, 2024 00:39 UTC
Cittadine AndrewChief Operating Officer
Exercise / conversionCommon Stock 8,952 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-24-000486 · rdgdoc.xml · nonDerivative · entry 1

Cittadine Andrew · CIK 0001863624 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,868

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents shares acquired on vesting and settlement of restricted stock units.

Read SEC document
December 31, 2023 Filed Jan 3, 2024 19:37 UTC Exercise / conversionRestricted Stock Units · Derivative 2,533 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-000483 · rdgdoc.xml · derivative · entry 3

STARR CHRISTOPHER M · CIK 0001235470 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,533 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units.

F3 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F3 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

Read SEC document
December 31, 2023 Filed Jan 3, 2024 19:37 UTC Exercise / conversionCommon Stock 2,533 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-24-000483 · rdgdoc.xml · nonDerivative · entry 1

STARR CHRISTOPHER M · CIK 0001235470 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,863

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents shares acquired on vesting and settlement of restricted stock units.

Read SEC document
December 31, 2023 Filed Jan 4, 2024 00:38 UTC Exercise / conversionRestricted Stock Units · Derivative 2,533 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-000484 · rdgdoc.xml · derivative · entry 3

KLAUSNER ARTHUR J · CIK 0001207790 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,533 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units.

F3 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F3 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

Read SEC document
December 31, 2023 Filed Jan 4, 2024 00:38 UTC Exercise / conversionCommon Stock 2,533 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-24-000484 · rdgdoc.xml · nonDerivative · entry 1

KLAUSNER ARTHUR J · CIK 0001207790 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,863

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents shares acquired on vesting and settlement of restricted stock units.

Read SEC document
December 31, 2023 Filed Jan 4, 2024 00:34 UTC
Tsuchimoto Kim RDirector · Chief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 9,957 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-000480 · rdgdoc.xml · derivative · entry 5

Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,556

Underlying: Common Stock · 9,957 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units.

F3 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F4 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 61,532 restricted stock units, vesting 6/48ths (7,692 shares) on June 30, 2022, and 3/48ths (3,846 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F5 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F3 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F4 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 61,532 restricted stock units, vesting 6/48ths (7,692 shares) on June 30, 2022, and 3/48ths (3,846 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

F5 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

Read SEC document
December 31, 2023 Filed Jan 4, 2024 00:34 UTC
Tsuchimoto Kim RDirector · Chief Financial Officer
Tax withholdingCommon Stock 4,073 $0.34 $1,385.63
Disclosure

SEC source: 0001437749-24-000480 · rdgdoc.xml · nonDerivative · entry 2

Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,870

F2 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.